Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma (Q48103938)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Demetra Mavri-Damelin

7

object named as

Demetra Mavri-Damelin

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

author name string

Charissa Mynhardt

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Leonard H Damelin

2

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Rupal Jivan

3

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Jade Peres

4

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Sharon Prince

5

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Robin B Veale

6

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

publication date

19 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Journal of Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

119

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

1

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

1193-1203

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

The Global Burden of Cancer 2013

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1).

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones).

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Repositioning metformin for cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

5-Fluorouracil: mechanisms of resistance and reversal strategies

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

The Tumor Microenvironment and DNA Repair

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Cellular pharmacology of gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Drug combination studies and their synergy quantification using the Chou-Talalay method

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCB.26291

21 January 2018

Identifiers

10.1002/JCB.26291

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 February 2018

http://europepmc.org/abstract/MED/28722177

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48103938&oldid=2184875029"